LIN TAI-AN (Chief Scientific Officer) received a stock award from SPRINGWORKS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/14/2025ACC: 0001104659-25-003464
Officer· Chief Scientific Officer
Since Sep 2023
+27.18K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
27.18K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.93K
Price / share
—
Trade value
—
% of position
26.5%
1/10/2025
26.11K→33.04K
Total
Net shares
+6.93K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/10/2025 | A · Award | +6.93K | — | — | 26.5% | 26.11K | 33.04K |
| Total | +6.93K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
20.25K shares
Shares
+20.25K
Strike price
43.00
Held after
20.25K
Exercisable
—
1/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock20.25K shares | 1/10/2025 | A · Award | +20.25K | 43.00 | — | 20.25K |